Triple therapy for first-time H. pylori eradication
Treatments studied
Part of Digestive system, Infections clinical trials.
This study tests a new combination of three medications (bismuth, tetracycline, and rabeprazole) to see if it can successfully get rid of H. pylori infection on the first try. The goal is to offer a simpler and effective treatment option for people who haven't been treated for H. pylori before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an H. pylori infection confirmed by a test (like a breath, stool, or biopsy test).
- You have not had H. pylori treatment before.
- You have not had stomach surgery to remove part of your stomach.
- You have not taken antibiotics in the last 4 weeks.
- You are not allergic to bismuth, tetracycline, or rabeprazole (the study medications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how long (10 or 14 days) a combination of four medicines (bismuth quadruple therapy) should be taken to best treat H. pylori infection, and whether the best duration differs between women and men. It aims to find the shortest effective treatment to reduce side effects.
This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.
This trial tests whether taking a special yeast (Saccharomyces boulardii) together with an antibiotic (minocycline) clears a first-time H. pylori stomach infection. It may help reduce side effects and improve treatment success.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
Hear when a new Helicobatcer Pylori trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.